UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating ketone bodies as signals for cardiovascular disease and mortality

European heart journal, 2023-05, Vol.44 (18), p.1647-1649

2023

Volltextzugriff (PDF)

Heart Failure Stimulates Tumor Growth by Circulating Factors

Circulation (New York, N.Y.), 2018-08, Vol.138 (7), p.678-691

2018

Volltextzugriff (PDF)

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

Cardiovascular diabetology, 2020-01, Vol.19 (1), p.5-5, Article 5

2020

Volltextzugriff (PDF)

Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues

The Journal of clinical investigation, 2021-09, Vol.131 (17), p.1-14

2021

Volltextzugriff (PDF)

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8631

2022

Volltextzugriff (PDF)

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

The American heart journal, 2017-03, Vol.185, p.140-149

2017

Volltextzugriff (PDF)

Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier

Journal of the American Heart Association, 2020-11, Vol.9 (22), p.e018641-e018641

2020

Volltextzugriff (PDF)

Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization

European heart journal, 2007-08, Vol.28 (16), p.2018-2027

2007

Volltextzugriff (PDF)

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction

Heart and vessels, 2022-02, Vol.37 (2), p.273-281

2022

Volltextzugriff (PDF)

Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma

Frontiers in cardiovascular medicine, 2022-07, Vol.9, p.915102-915102

2022

Volltextzugriff (PDF)

Ketone Body Exposure of Cardiomyocytes Impairs Insulin Sensitivity and Contractile Function through Vacuolar-Type H+-ATPase Disassembly—Rescue by Specific Amino Acid Supplementation

International journal of molecular sciences, 2022-11, Vol.23 (21), p.12909

2022

Volltextzugriff (PDF)

Comorbidities complicating heart failure: changes over the last 15 years

Clinical research in cardiology, 2023-01, Vol.112 (1), p.123-133

2023

Volltextzugriff (PDF)

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy

Biological research, 2021-02, Vol.54 (1), p.3-3, Article 3

2021

Volltextzugriff (PDF)

A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise

Scientific reports, 2023-11, Vol.13 (1), p.18822-18822, Article 18822

2023

Volltextzugriff (PDF)

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling

Scientific reports, 2023-03, Vol.13 (1), p.4046-4046, Article 4046

2023

Volltextzugriff (PDF)

Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11906

2021

Volltextzugriff (PDF)

The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise

Pflügers Archiv, 2021-08, Vol.473 (8), p.1301-1313

2021

Volltextzugriff (PDF)

Mitochondrial Reprogramming Induced by CaMKIIδ Mediates Hypertrophy Decompensation

Circulation research, 2015-02, Vol.116 (5), p.e28-e39

2015

Volltextzugriff (PDF)

SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

지질·동맥경화학회지, 2022, 11(1), , pp.1-19

2022

Volltextzugriff (PDF)

Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure

Clinical research in cardiology, 2009-02, Vol.98 (2), p.121-129

2009

Volltextzugriff (PDF)

IGF-1 boosts mitochondrial function by a Ca2+ uptake-dependent mechanism in cultured human and rat cardiomyocytes

Frontiers in physiology, 2023-02, Vol.14, p.1106662-1106662

2023

Volltextzugriff (PDF)

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

Cardiovascular drugs and therapy, 2021-10, Vol.35 (5), p.953-963

2021

Volltextzugriff (PDF)

Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure

Cardiovascular research, 2010-07, Vol.87 (1), p.30-39

2010

Volltextzugriff (PDF)

ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ

International journal of molecular sciences, 2021-05, Vol.22 (9), p.4427

2021

Volltextzugriff (PDF)

Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2021-04, Vol.77 (13), p.1660-1669

2021

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(107)
Buchkapitel
(1)

Sprache

Englisch
(108)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating ketone bodies as signals for cardiovascular disease and mortality

Heart Failure Stimulates Tumor Growth by Circulating Factors

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier

Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction

Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma

Ketone Body Exposure of Cardiomyocytes Impairs Insulin Sensitivity and Contractile Function through Vacuolar-Type H+-ATPase Disassembly—Rescue by Specific Amino Acid Supplementation

Comorbidities complicating heart failure: changes over the last 15 years

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy

A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling

Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes

The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise

Mitochondrial Reprogramming Induced by CaMKIIδ Mediates Hypertrophy Decompensation

SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure

IGF-1 boosts mitochondrial function by a Ca2+ uptake-dependent mechanism in cultured human and rat cardiomyocytes

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure

ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ

Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review

Suchergebnisse filtern